Continue to site >
Trending ETFs

Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

-

$31.8 M

-

3.53%

Vitals

YTD Return

N/A

1 yr return

-9.2%

3 Yr Avg Return

4.3%

5 Yr Avg Return

5.9%

Net Assets

$31.8 M

Holdings in Top 10

24.9%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 3.53%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 210.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$100,000

IRA

$100,000


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

-

$31.8 M

-

3.53%

TMSEX - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return 4.3%
  • 5 Yr Annualized Total Return 5.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -2.38%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Turner Medical Sciences Long/Short Fund
  • Fund Family Name
    Turner Funds
  • Inception Date
    Feb 07, 2011
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    John P. Fraunces

Fund Description


TMSEX - Performance

Return Ranking - Trailing

Period TMSEX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -14.5% 32.5% N/A
1 Yr -9.2% -26.8% 13.4% N/A
3 Yr 4.3%* -25.8% 13.6% N/A
5 Yr 5.9%* -24.7% 12.0% N/A
10 Yr N/A* -12.4% 10.8% N/A

* Annualized

Return Ranking - Calendar

Period TMSEX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -24.8% 12.7% N/A
2022 N/A -46.3% 26.8% N/A
2021 N/A -20.0% 25.3% N/A
2020 N/A -22.2% 14.0% N/A
2019 N/A -24.3% 60.7% N/A

Total Return Ranking - Trailing

Period TMSEX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -14.5% 32.5% N/A
1 Yr -9.2% -26.6% 13.4% N/A
3 Yr 4.3%* -9.2% 13.6% N/A
5 Yr 5.9%* -9.4% 15.9% N/A
10 Yr N/A* -7.5% 13.2% N/A

* Annualized

Total Return Ranking - Calendar

Period TMSEX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -24.8% 12.7% N/A
2022 N/A -12.7% 26.8% N/A
2021 N/A -15.5% 25.3% N/A
2020 N/A -17.3% 22.6% N/A
2019 N/A -15.0% 64.3% N/A

TMSEX - Holdings

Concentration Analysis

TMSEX Category Low Category High TMSEX % Rank
Net Assets 31.8 M 2.32 M 8.1 B N/A
Number of Holdings 38 3 2278 N/A
Net Assets in Top 10 13 M -162 M 2.09 B N/A
Weighting of Top 10 24.86% 0.0% 98.8% N/A

Top 10 Holdings

  1. Pfizer Inc 2.62%
  2. GlaxoSmithKline PLC ADR 2.62%
  3. Allergan PLC 2.62%
  4. Abbott Laboratories 2.55%
  5. Merck & Co Inc 2.49%
  6. UnitedHealth Group Inc 2.46%
  7. Edwards Lifesciences Corp 2.46%
  8. bluebird bio Inc 2.42%
  9. C.R. Bard Inc 2.38%
  10. Ionis Pharmaceuticals Inc 2.23%

Asset Allocation

Weighting Return Low Return High TMSEX % Rank
Stocks
54.64% -0.11% 107.30% N/A
Cash
45.14% -17.34% 100.06% N/A
Other
0.21% -4.18% 46.57% N/A
Preferred Stocks
0.00% -0.64% 2.67% N/A
Convertible Bonds
0.00% -0.01% 2.82% N/A
Bonds
0.00% -9.01% 92.61% N/A

Stock Sector Breakdown

Weighting Return Low Return High TMSEX % Rank
Healthcare
54.64% -2.86% 48.92% N/A
Utilities
0.00% -4.19% 11.21% N/A
Technology
0.00% -4.90% 37.98% N/A
Real Estate
0.00% -9.01% 40.55% N/A
Industrials
0.00% -9.10% 21.99% N/A
Financial Services
0.00% 0.00% 33.33% N/A
Energy
0.00% 0.00% 18.75% N/A
Communication Services
0.00% -4.54% 10.19% N/A
Consumer Defense
0.00% -7.58% 18.29% N/A
Consumer Cyclical
0.00% -6.55% 27.34% N/A
Basic Materials
0.00% -2.16% 16.56% N/A

Stock Geographic Breakdown

Weighting Return Low Return High TMSEX % Rank
US
48.82% -0.11% 105.83% N/A
Non US
5.82% -0.84% 93.74% N/A

TMSEX - Expenses

Operational Fees

TMSEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 3.53% 0.42% 4.90% N/A
Management Fee 1.50% 0.25% 2.25% N/A
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.15% 0.01% 0.55% N/A

Sales Fees

TMSEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

TMSEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

TMSEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 210.00% 0.00% 5067.00% N/A

TMSEX - Distributions

Dividend Yield Analysis

TMSEX Category Low Category High TMSEX % Rank
Dividend Yield 0.00% 0.00% 0.12% N/A

Dividend Distribution Analysis

TMSEX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

TMSEX Category Low Category High TMSEX % Rank
Net Income Ratio -2.38% -2.95% 1.42% N/A

Capital Gain Distribution Analysis

TMSEX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

TMSEX - Fund Manager Analysis

Managers

John P. Fraunces


Start Date

Tenure

Tenure Rank

Feb 27, 2015

1.84

1.8%

John P. Fraunces, Jr. Portfolio Manager/Global Equity Analyst Turner Investments John Fraunces is a Portfolio Manager/Global Equity Analyst on Turner’s health care team and Co-Portfolio Manager of the Global Medical Sciences Long/Short strategy. Mr. Fraunces joined Turner in 2015 covering stocks in the health care sector and has 20 years of investment experience. Prior to joining Turner Investments, Mr. Fraunces was a managing member and portfolio manager of Synaptic Capital Group, LLC. He previously held portfolio management, analyst, research, and consulting positions at Solaris Asset management LLC, Gardner Lewis Asset Management, Vector Securities International, PaineWebber Incorporated, IMS America, Ltd, and Magainin Pharmaceuticals, Inc. Mr. Fraunces earned his MBA at Lehigh University and earned a bachelor’s degree in chemistry at University of Scranton.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.18 41.03 6.74 5.53